• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for local and nodal recurrence in patients with head and neck cutaneous squamous cell carcinoma in a high-reference oncological center in Poland.波兰一家高参考肿瘤中心头颈皮肤鳞状细胞癌患者局部和淋巴结复发的危险因素
Rep Pract Oncol Radiother. 2024 Jun 6;29(2):204-210. doi: 10.5603/rpor.99904. eCollection 2024.
2
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.头颈部皮肤鳞状细胞癌的淋巴结转移
Laryngoscope. 2005 Sep;115(9):1561-7. doi: 10.1097/01.mlg.0000173202.56739.9f.
3
Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.头颈部皮肤鳞状细胞癌淋巴结转移相关危险因素分析
Eur Arch Otorhinolaryngol. 2015 Oct;272(10):3007-12. doi: 10.1007/s00405-014-3261-6. Epub 2014 Sep 13.
4
Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.头颈部皮肤鳞状细胞癌复发及区域淋巴结肿大的相关因素
Otolaryngol Head Neck Surg. 2017 May;156(5):863-869. doi: 10.1177/0194599817697053. Epub 2017 Mar 21.
5
Outcomes of Sentinel Lymph Node Biopsy for Primary Cutaneous Squamous Cell Carcinoma of the Head and Neck.头颈部原发性皮肤鳞状细胞癌前哨淋巴结活检的结果
Dermatol Surg. 2022 Feb 1;48(2):157-161. doi: 10.1097/DSS.0000000000003304.
6
Tumour Recurrence, Depth of Invasion, and Temple Location as Independent Prognostic Parameters of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinomas.肿瘤复发、侵袭深度和 temple 位置是头颈部皮肤鳞状细胞癌淋巴结转移的独立预后参数。
Int J Clin Pract. 2024 Mar 8;2024:9960948. doi: 10.1155/2024/9960948. eCollection 2024.
7
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and Neck.头颈部皮肤鳞状细胞癌前哨淋巴结活检。
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1171-1176. doi: 10.1001/jamaoto.2016.1927.
8
The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.老年头颈部皮肤鳞状细胞癌的初级和辅助放疗的价值。
Radiat Oncol. 2021 Jun 12;16(1):105. doi: 10.1186/s13014-021-01832-3.
9
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.非黑色素瘤皮肤癌:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S125-S132. doi: 10.1017/S0022215116000554.
10
Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip.唇部皮肤鳞状细胞癌中外翻 vs 皮肤红唇位置与淋巴结转移和死亡率的关联。
JAMA Dermatol. 2018 Jun 1;154(6):701-707. doi: 10.1001/jamadermatol.2018.0792.

引用本文的文献

1
Daylight photodynamic therapy in nonmelanoma skin cancers and photorejuvenation.日光光动力疗法在非黑素瘤皮肤癌及光嫩肤中的应用
Rep Pract Oncol Radiother. 2025 Aug 7;30(3):417-423. doi: 10.5603/rpor.106158. eCollection 2025.
2
lncRNA Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients.长链非编码RNA是HPV感染的标志物及头颈部鳞状细胞癌患者的预后因素。
Biomedicines. 2025 Mar 26;13(4):798. doi: 10.3390/biomedicines13040798.

本文引用的文献

1
miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology.头颈部鳞状细胞癌中的微小RNA:个性化肿瘤学前景光明但仍任重道远
Rep Pract Oncol Radiother. 2023 Nov 16;28(5):681-697. doi: 10.5603/rpor.96666. eCollection 2023.
2
The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma.炎症相关因子在头颈部鳞状细胞癌中的作用
J Inflamm Res. 2023 Sep 27;16:4301-4315. doi: 10.2147/JIR.S428358. eCollection 2023.
3
Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review.基因多态性与头颈部鳞状细胞癌风险:一项系统评价
Rep Pract Oncol Radiother. 2022 Dec 29;27(6):1058-1076. doi: 10.5603/RPOR.a2022.0115. eCollection 2022.
4
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma.晚期皮肤鳞状细胞癌的危险因素与诊断
Dermatol Pract Concept. 2021 Sep 1;11(Suppl 2):e2021166S. doi: 10.5826/dpc.11S2a166S. eCollection 2021 Nov.
5
Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review.头颈部皮肤鳞状细胞癌的预后因素:系统评价。
J Otolaryngol Head Neck Surg. 2021 Sep 7;50(1):54. doi: 10.1186/s40463-021-00529-7.
6
Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.识别头颈部皮肤鳞状细胞癌预后的风险因素:系统评价和荟萃分析。
PLoS One. 2020 Sep 29;15(9):e0239586. doi: 10.1371/journal.pone.0239586. eCollection 2020.
7
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.欧洲多学科指南:侵袭性鳞状细胞皮肤癌——第 1 部分:流行病学、诊断和预防。
Eur J Cancer. 2020 Mar;128:60-82. doi: 10.1016/j.ejca.2020.01.007. Epub 2020 Feb 26.
8
Dermatopathology 101. Part 2 - Skin tumors.皮肤病理学 101. 第 2 部分 - 皮肤肿瘤。
J Dtsch Dermatol Ges. 2017 Sep;15(9):906-929. doi: 10.1111/ddg.13320. Epub 2017 Aug 25.
9
Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.头颈部皮肤鳞状细胞癌复发及区域淋巴结肿大的相关因素
Otolaryngol Head Neck Surg. 2017 May;156(5):863-869. doi: 10.1177/0194599817697053. Epub 2017 Mar 21.
10
Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.头颈部转移性皮肤鳞状细胞癌的预后标志物
Head Neck. 2017 Apr;39(4):772-778. doi: 10.1002/hed.24683. Epub 2017 Feb 15.

波兰一家高参考肿瘤中心头颈皮肤鳞状细胞癌患者局部和淋巴结复发的危险因素

Risk factors for local and nodal recurrence in patients with head and neck cutaneous squamous cell carcinoma in a high-reference oncological center in Poland.

作者信息

Pazdrowski Jakub, Szewczyk Mateusz, Pazdrowski Pawel, Seraszek-Jaros Agnieszka, Niewinski Patryk, Golusiński Wojciech

机构信息

Department of Head and Neck Surgery, Poznan University of Medical Sciences, The Greater Poland Cancer Center, Poznan, Poland.

Head and Neck Surgery Student Group, Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Rep Pract Oncol Radiother. 2024 Jun 6;29(2):204-210. doi: 10.5603/rpor.99904. eCollection 2024.

DOI:10.5603/rpor.99904
PMID:39143967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11321774/
Abstract

BACKGROUND

The behavior of cutaneous squamous cell carcinoma (cSCC) of the head and neck remains poorly understood. There is much controversy regarding the risk of local and nodal recurrences, as well as individual/environmental factors that increase the risk, such as tumor size, perineural invasion, and the state of the immune system. The objective was to analyze factors influencing local and/or regional lymph node recurrence in patients with cSCC in the head and neck region.

MATERIAL AND METHODS

This retrospective single-centre study included 521 patients with cSCC of the head and neck region, with local recurrence observed in 11% and nodal recurrence in 5%. Various potential risk factors were analyzed.

RESULTS

Statistically significant risk factors for both local and nodal recurrence include: tumor recurrence (p < 0.0001, p < 0.0001 respectively), tissue inflammation confirmed histopathologically (p < 0.0001, p = 0.0019, respectively), tumor size ≥ 10 mm (p = 0.018, p = 0.0056, respectively), invasion depth > 2 mm (p = 0.0238, p = 0.0031, respectively). Risk factors significant only for local recurrence include: surgical margins (p = 0.0056), tumor differentiation grade (p = 0.0149). No risk factors were found to be significant solely for nodal recurrence.

CONCLUSION

The authors argue that, in addition to classically recognized risk factors for local and nodal recurrence, attention should be paid to the presence of tissue inflammation confirmed histopathologically. It is also suggested to consider a tumor size of 10 mm as a threshold, increasing the risk of recurrence, instead of the frequently proposed 20 mm.

摘要

背景

头颈部皮肤鳞状细胞癌(cSCC)的行为仍未得到充分了解。关于局部和淋巴结复发风险以及增加风险的个体/环境因素,如肿瘤大小、神经周围侵犯和免疫系统状态,存在诸多争议。目的是分析影响头颈部区域cSCC患者局部和/或区域淋巴结复发的因素。

材料与方法

这项回顾性单中心研究纳入了521名头颈部区域cSCC患者,局部复发率为11%,淋巴结复发率为5%。分析了各种潜在风险因素。

结果

局部和淋巴结复发的统计学显著风险因素包括:肿瘤复发(分别为p < 0.0001,p < 0.0001)、组织学证实的组织炎症(分别为p < 0.0001,p = 0.0019)、肿瘤大小≥10 mm(分别为p = 0.018,p = 0.0056)、浸润深度>2 mm(分别为p = 0.0238,p = 0.0031)。仅对局部复发有显著意义的风险因素包括:手术切缘(p = 0.0056)、肿瘤分化程度(p = 0.0149)。未发现仅对淋巴结复发有显著意义的风险因素。

结论

作者认为,除了经典认识到的局部和淋巴结复发风险因素外,应关注组织学证实的组织炎症的存在。还建议将10 mm的肿瘤大小视为增加复发风险的阈值,而不是经常提出的20 mm。